Publications by authors named "Michael Pfleiderer"

Claim this Profile
O
Official batch control of influenza vaccines: Is it still useful?
Evelyne Kretzschmar, Heide Muckenfuss, Michael Pfleiderer

Vaccine· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of multi-country joint regulatory reviews: The experience of a WHO joint technical consultation on the CYD-TDV (Dengvaxia®) dossier.
Kirsten Vannice, Liliana Chocarro, Michael Pfleiderer, Ahmed Bellah, Michael Ward

Vaccine· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New bone post-processing tools in forensic imaging: a multi-reader feasibility study to evaluate detection time and diagnostic accuracy in rib fracture assessment.
Philip A Glemser, Michael Pfleiderer, Anna Heger, Jan Tremper, Astrid Krauskopf

Int J Legal Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations of strategies to provide influenza vaccine year round.
Philipp Lambach, Alba Maria Ropero Alvarez, Siddhivinayak Hirve, Justin R Ortiz, Joachim Hombach, Michael Pfleiderer

Vaccine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[From the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany : criteria for the assessment of benefits and risks].
Michael Pfleiderer, Ole Wichmann

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary of knowledge gaps related to quality and efficacy of current influenza vaccines.
Michael Pfleiderer, Jean-Hugues Trouvin, Daniel Brasseur, Marta Gränstrom, Ragini Shivji

Vaccine· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A global regulatory science agenda for vaccines.
Lindsay Elmgren, Xuguang Li, Carolyn Wilson, Robert Ball, Junzhi Wang, Michael Pfleiderer

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of assays for influenza vaccine immunogenicity determination: progress towards consistency.
Ralf Wagner, Michael Pfleiderer

Expert Rev Vaccines· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach.
Ralf Wagner, Constanze Göpfert, Joanna Hammann, Britta Neumann, John Wood, Michael Pfleiderer

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Flu vaccines].
Michael Pfleiderer

Pharm Unserer Zeit· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469.
Elisabeth Christiansen, Maria E Due-Hansen, Christian Urban, Nicole Merten, Michael Pfleiderer

ACS Med Chem Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human clinical trials with vaccines--what regulators want.
Karen B Goetz, Michael Pfleiderer, Christian K Schneider

Nat Biotechnol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of vaccines - bridging from stability data to continuous safety and efficacy throughout shelf life - an always reliable approach?
Michael Pfleiderer

Biologicals· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination safety update.
Burkhard Schneeweiss, Michael Pfleiderer, Brigitte Keller-Stanislawski

Dtsch Arztebl Int· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Production and quality control of vaccines].
Michael Pfleiderer

Pharm Unserer Zeit· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marketing authorization for recombinant products in Europe.
Michael Pfleiderer

Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis